Dominant-negative c-Jun (TAM67) target genes: HMGA1 is required for tumor promoter-induced transformation (Q40570030)

21 September 2017

title

Dominant-negative c-Jun (TAM67) target genes: HMGA1 is required for tumor promoter-induced transformation (English)

1 reference

21 September 2017

Arindam Dhar

1

1 reference

21 September 2017

Jing Hu

2

1 reference

21 September 2017

Raymond Reeves

3

1 reference

21 September 2017

Linda M S Resar

4

1 reference

21 September 2017

Nancy H Colburn

5

1 reference

21 September 2017

language of work or name

English

0 references

publication date

1 May 2004

1 reference

21 September 2017

1 reference

21 September 2017

volume

23

1 reference

21 September 2017

issue

25

1 reference

21 September 2017

page(s)

4466-4476

1 reference

Function and regulation of AP-1 subunits in skin physiology and pathology

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207581

Cancer genetics: from Boveri and Mendel to microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207581

Thyroid cell transformation requires the expression of the HMGA1 proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207581

12-O-tetradecanoylphorbol-13-acetate--induced levels of AP-1 proteins: a 46-kDa protein immunoprecipitated by anti-fra-1 and induced in promotion-resistant but not promotion-sensitive JB6 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207581

AP1/jun function is differentially induced in promotion-sensitive and resistant JB6 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207581

HMG-I(Y) and the CBP/p300 coactivator are essential for human papillomavirus type 18 enhanceosome transcriptional activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207581

Increased expression of p50-NF-kappaB and constitutive activation of NF-kappaB transcription factors during mouse skin carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207581

Osteopontin induction is required for tumor promoter-induced transformation of preneoplastic mouse cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207581

Enhancement of serum-response factor-dependent transcription and DNA binding by the architectural transcription factor HMG-I(Y)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207581

Close encounters of many kinds: Fos-Jun interactions that mediate transcription regulatory specificity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207581

Tumor promoter induces high mobility group HMG-Y protein expression in transformation-sensitive but not -resistant cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207581

Differentially expressed protein Pdcd4 inhibits tumor promoter-induced neoplastic transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207581

Tumour promoter induces anchorage independence irreversibly

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207581

Dissociation of mitogenesis and late-stage promotion of tumor cell phenotype by phorbol esters: mitogen-resistant variants are sensitive to promotion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207581

The role of AP-1, NF-kappaB and ROS/NOS in skin carcinogenesis: the JB6 model is predictive

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207581

Blocking of tumor promoter-induced AP-1 activity inhibits induced transformation in JB6 mouse epidermal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207581

Transformation reversion induced in JB6 RT101 cells by AP-1 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207581

Mechanisms of transcriptional synergism between distinct virus-inducible enhancer elements

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207581

Promotion-sensitive epidermal and mammary epithelial cells maintained in suspension over agarose.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207581

Organization, inducible-expression and chromosome localization of the human HMG-I(Y) nonhistone protein gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207581

A requirement for extracellular signal-regulated kinase (ERK) function in the activation of AP-1 by Ha-Ras, phorbol 12-myristate 13-acetate, and serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207581

21 January 2018

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207581

The extracellular-signal-regulated protein kinases (Erks) are required for UV-induced AP-1 activation in JB6 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207581

Shortage of mitogen-activated protein kinase is responsible for resistance to AP-1 transactivation and transformation in mouse JB6 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207581

AP-1 in mouse development and tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207581

Regulation of a multigenic invasion programme by the transcription factor, AP-1: re-expression of a down-regulated gene, TSC-36, inhibits invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207581

AP-1 function and regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207581

Mechanisms of carcinogenesis: focus on oxidative stress and electron transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207581

Cooperativity between two NF-kappa B complexes, mediated by high-mobility-group protein I(Y), is essential for cytokine-induced expression of the E-selectin promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207581

Induced expression of dominant-negative c-jun downregulates NFkappaB and AP-1 target genes and suppresses tumor phenotype in human keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207581

Differential regulation of a multipromoter gene. Selective 12-O-tetradecanoylphorbol-13-acetate induction of a single transcription start site in the HMG-I/Y gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207581

Transcriptional regulation of cell invasion: AP-1 regulation of a multigenic invasion programme

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207581

Sequence and analysis of the murine Hmgiy (Hmga1) gene locus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207581

Architectural transcription factor HMGI(Y) promotes tumor progression and mesenchymal transition of human epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207581

AP-1 in cell proliferation and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207581

Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207581

AP-1, NF-kappa-B, and ERK activation thresholds for promotion of neoplastic transformation in the mouse epidermal JB6 model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207581

Virus induction of human IFN beta gene expression requires the assembly of an enhanceosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207581

Distinct roles of Jun : Fos and Jun : ATF dimers in oncogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207581

c-jun and multistage carcinogenesis: association of overexpression of introduced c-jun with progression toward a neoplastic endpoint in mouse JB6 cells sensitive to tumor promoter-induced transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207581

Expression of dominant negative Erk2 inhibits AP-1 transactivation and neoplastic transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207581

I kappa B proteins: structure, function and regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207581

HMG-I/Y, a new c-Myc target gene and potential oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207581

Inhibition of carcinogenesis by tea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207581

The transformation suppressor Pdcd4 is a novel eukaryotic translation initiation factor 4A binding protein that inhibits translation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207581

A novel transformation suppressor, Pdcd4, inhibits AP-1 transactivation but not NF-kappaB or ODC transactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207581

Protection against human papillomavirus type 16-E7 oncogene-induced tumorigenesis by in vivo expression of dominant-negative c-jun

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207581

Transgenic mice demonstrate AP-1 (activator protein-1) transactivation is required for tumor promotion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207581

Transactivation of Fra-1 and consequent activation of AP-1 occur extracellular signal-regulated kinase dependently

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207581

Promising molecular targets for cancer prevention: AP-1, NF-kappa B and Pdcd4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207581

High-mobility-group chromosomal proteins: architectural components that facilitate chromatin function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207581

7 January 2021

High mobility group protein I(Y) is required for function and for c-Rel binding to CD28 response elements within the GM-CSF and IL-2 promoters

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207581

7 January 2021

The role of high-mobility group I(Y) proteins in expression of IL-2 and T cell proliferation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207581

7 January 2021

Purification and assays for high mobility group HMG-I(Y) protein function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207581

7 January 2021

Early overexpression of cyclin D1 protein in mouse skin carcinogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207581

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1207581

1 reference

Dimensions Publication ID

21 September 2017

1002139695

0 references

1 reference